Recurrent Vulvovaginal Candidiasis
Reproductive·MeSH: Candidiasis, Vulvovaginal
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| brexafemme | SCYNEXIS INC (SCYX) |
Deep-dive into Recurrent Vulvovaginal Candidiasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis